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Abstract
The receptor tyrosine kinase RET plays an essential role during embryogenesis in regulating cell proliferation, differentiation,
and migration. Upon glial cell line-derived neurotrophic factor (GDNF) stimulation, RET can trigger multiple intracellular
signaling pathways that in concert activate various downstream effectors. Here we report that the RET receptor induces
calcium (Ca
2+) signaling and regulates neocortical neuronal progenitor migration through the Phospholipase-C gamma
(PLCc) binding domain Tyr1015. This signaling cascade releases Ca
2+ from the endoplasmic reticulum through the inositol
1,4,5-trisphosphate receptor and stimulates phosphorylation of ERK1/2 and CaMKII. A point mutation at Tyr1015 on RET or
small interfering RNA gene silencing of PLCc block the GDNF-induced signaling cascade. Delivery of the RET mutation to
neuronal progenitors in the embryonic ventricular zone using in utero electroporation reveal that Tyr1015 is necessary for
GDNF-stimulated migration of neurons to the cortical plate. These findings demonstrate a novel RET mediated signaling
pathway that elevates cytosolic Ca
2+ and modulates neuronal migration in the developing neocortex through the PLCc
binding domain Tyr1015.
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Introduction
RET (REarranged during Transfection) was initially identified as
an oncogene [1], but several additional important functions during
development and disease have since been discovered [2,3,4]. The
RET gene, on human chromosome 10q11.2, encodes a receptor
tyrosine kinase that is activated by the glial cell line-derived
neurotrophic factor (GDNF) family of ligands in conjunction
with ligand-specific co-receptors of the GDNF-family receptor-a
(GFRa) [5,6]. GDNF/GFRa-activation of RET results in trans-
phosphorylation of tyrosine residues in its intracellular kinase
domain that triggers multiple intracellular signaling pathways that
in concert regulate cell proliferation, migration, differentiation,
survival, neurite outgrowth, and synaptic plasticity [2]. Loss-of-
function mutations in RET cause Hirschsprung’s disease, a de-
velopmental disorder of the enteric nervous system [7], whereas
gain-of-function mutations cause multiple endocrine neoplasia type
2a or b (MEN2a/b), a dominantly inherited cancer syndrome [8].
RET mediated signaling in the nervous system has for the most part
been studied in cell lineages derived from the neural crest [9].
However, since both GDNF, GFRa1 and RET are expressed in
the embryonic neocortex [10], there is a growing interest in
understanding the role of RET and its ligands in the centralnervous
system [11,12,13].
The intracellular domain of the RET protein has several
tyrosine residues that become auto-phosphorylated upon ligand
interaction and mediate activation of various downstream sig-
naling targets, including the mitogen-activated protein kinase
(MAPK) [3,14] and the calcium/calmodulin-dependent protein
kinase II (CaMKII) [15]. Mutating RET tyrosine residue 1062
(Tyr1062) gives a phenotype that largely resembles RET deletion
mutants [16,17]. Phosphorylated Tyr1062 tethers transduction
effectors (including SHC, FRS2 and IRS1 family proteins [2]) to
activate several signaling pathways including the Phosphatidyli-
nositol 3-kinase (PI3K)/Akt and Ras/MAPK cascades [7]. A
different RET tyrosine residue, Tyr1015, stimulates the phospho-
lipase C c (PLCc) pathway [18]. Mice bearing Tyr1015 point
mutation resulting in disrupted PLCc activation show abnormal
kidney development and death at 1 month of age [19]. While these
findings have expanded our understanding of RET Tyr1015, little
is known about downstream signaling pathways activated by RET-
phosphorylated PLCc. One potential signaling pathway that is
modulated by PLCc is cytosolic calcium (Ca
2+) signaling.
The Ca
2+ ion serves as a universal cytosolic messenger to
control a diverse range of cellular processes in both disease and
development [20,21]. Transporters of Ca
2+ handle the temporal
and spatial distribution of cytosolic Ca
2+ by regulating influx
and efflux from the extracellular milieu or release from the
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2+ from
ER mainly occurs through the inositol 1,4,5-trisphosphate (InsP3)
receptor (InsP3R). The InsP3R is activated by Ca
2+ itself or by
InsP3 that is produced when PLC cleaves phosphatidylinositol 4,5-
bisphosphate. An elevated cytosolic Ca
2+ concentration triggers
various downstream effectors such as MAPK and CaMKII, which
subsequently modulate cellular processes including neuronal mi-
gration, axon and dendrite development and regeneration, and
synaptic plasticity [23,24,25].
We here demonstrate that RET receptor activation by GDNF
stimulates cytosolic Ca
2+ signaling through a PLCc phosphotyr-
osine binding site at Tyr1015. This GDNF/RET/PLCc/InsP3R
signaling cascade triggers release of Ca
2+ from internal ER stores
that subsequently phosphorylates p42/44 of MAPK (ERK1/2)
and CaMKII. Additionally, we report that RET is present in the
neocortex of the developing brain and that overexpressing a RET
Tyr1015 point mutation perturbs GDNF-stimulated migration of
neocortical neuronal progenitor cells.
Results
Calcium Signaling
Single-cell live Ca
2+ imaging in HeLa cells was used to de-
termine whether the RET receptor was involved in cytosolic Ca
2+
signaling. Cells were transfected with green fluorescent protein
(GFP)-tagged wild-type RET (RET
WT) 24 h prior to loading with
the Ca
2+-sensitive dye Fura-2/AM (Figure 1A and B). The
cytosolic Ca
2+ concentration was exclusively examined in GFP
positive cells. Treatment with GDNF and GFRa1 in RET
WT ex-
pressing cells resulted in a rapid cytosolic Ca
2+ increase in 58% of
the cells whereas an oscillatory Ca
2+ response was observed in
25% of the cells (Table 1 and Figure 1C).
Equivalent GFP-tagged RET constructs, bearingpoint mutations
at tyrosine residues at positions 1062 (RET
1062), 1015 (RET
1015)o r
both (RET
1062/1015), were used to identify a tyrosine residue that
mediated the Ca
2+ response (Figure 1A and Figure S1A). The
RET
1015 mutation abolished all cytosolic Ca
2+ elevation (Table 1
and Figure 1D), whereas the RET
1062 mutation had no significant
effect on the Ca
2+ response triggered by GDNF (Table 1 and
Figure 1E). Cells expressing the double point mutation RET
1015/
1062 also failed to evoke a Ca
2+ increase (Table 1 and Figure 1F).
RET receptor-activation by GDNF therefore triggers cellular Ca
2+
responses by a molecular mechanism involving Tyr1015, but not
Tyr1062.
Signaling Pathway
The mechanism by which GDNF stimulated Ca
2+ signaling was
determined by using single cell Ca
2+ recordings while blocking
various known Ca
2+-regulators with small molecule inhibitors or
small interfering RNA (siRNA). Tyr1015 is known to bind PLCc
to the RET receptor, suggesting that PLC played a role in this
signaling pathway. The effect of the PLC-inhibitor U73122 was
therefore examined. GDNF failed to elevate cytosolic Ca
2+ in
Figure 1. GDNF induces cytosolic Ca
2+ signaling through Tyr1015 of RET. (A) Schematic representation of GFP-tagged RET constructs.
(B) Constructs expressed in HeLa cells. (C–F) Representative single-cell Ca
2+ recordings of GFP positive HeLa cells loaded with Fura-2/AM and
subsequently treated with GDNF (100 ng/ml). (C) Cells expressing the RET
WT construct responded to GDNF with either Ca
2+ transient (top trace) or
Ca
2+ oscillations (bottom trace). Cells expressing RET
1015 (D) or RET
1015/1062 (F) failed to trigger a Ca
2+ response following GDNF exposure. Cells
expressing RET
1062 (E) responded to GDNF in a similar manner as cells expressing RET
WT.
doi:10.1371/journal.pone.0031258.g001
Table 1. Characteristics of Ca
2+ responses induced by GDNF
in cells expressing various RET constructs.
non-responding
a transient
b oscillation
c
%( n)% ( n)% ( n)[ n/N]
d
GDNF/
GFRa1
GFP 99.0 (312) 0.6 (2) 0.3 (1) [315/5]
RET
WT 17.0 (66) 58.1 (226) 24.9 (97) [389/6]
RET
1015 99.1 (338) 0.6 (2) 0.3 (1) [341/6]
RET
1062 9.2 (33) 66.0 (237) 24.8 (89) [359/5]
RET
1015/1062 100.0 (421) 0 (0) 0 (0) [421/5]
aNon-responding cells have no Ca
2+ increase exceeding 1.25 of the baseline.
bTransient responding cells have one Ca
2+ peak exceeding 1.25 of the baseline.
cOscillatory responding cells have at least three Ca
2+ peaks exceeding 1.25 of
the baseline.
d[number of cells/number of experiments].
doi:10.1371/journal.pone.0031258.t001
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WT expressing cells that were pre-treated with U73122
(Table 2 and Figure 2A). A siRNA against the PLCc mRNA was
used as an alternative method to ablate the PLCc function. The
PLCc-siRNA drastically reduced PLCc (Figure S1B) and blocked
the GDNF-induced Ca
2+ increase in cells expressing RET
WT
(Table 2 and Figure 2B). The mock-siRNA failed to abolish the
Ca
2+ response (Figure 2C).
Two key proteins involved in Ca
2+ release from the ER are the
InsP3R and the Ryanodine receptor (RyR). Exposing RET
WT
expressing cells to the InsP3R inhibitor 2-aminoethoxydiphenyl
borate (2-APB) blocked the cytosolic Ca
2+ increase triggered by
GDNF (Table 2 and Figure 2D). In contrast, preincubating cells
with Ryanodine, which prevents Ca
2+ release through RyR,
produced no significant change in the Ca
2+ response (Table 2 and
Figure 2Ea). Another RyR blocker Dantrolene, also failed to
inhibit the GDNF-induced Ca
2+ response (Figure 2Eb).
Blocking the sarco/endoplasmic reticulum Ca
2+-ATPase (SER-
CA) pump depletes the ER of Ca
2+, so that cytosolic Ca
2+ can no
longer be elevated from ER Ca
2+ stores. Pre-treatment of RET
WT
expressing cells with the SERCA pump inhibitor Thapsigargin
triggered a typical cytosolic transient Ca
2+ increase as the ER stores
depleted. Subsequent GDNF exposure failed to elevate free cy-
tosolicCa
2+ (Table 2 and Figure 2F). GDNF-induced cytosolicCa
2+
signaling therefore appeared to come from the ER.
The contribution of extracellular Ca
2+ was also investigated
by recordings in Ca
2+ free medium. The GDNF-induced cytosolic
Figure 2. A RET/PLCc/InsP3R-cascade stimulates GDNF-induced Ca
2+ release. (A–H) Representative single-cell Ca
2+ recordings of GFP
positive RET
WT expressing cells loaded with Fura-2/AM and preincubated with inhibitors as indicated, following treatment with GDNF (100 ng/ml).
Inhibiting PLC with U73122 (5 mM) (A) or knocking down PLCc with siRNA (B) blocked the cytosolic Ca
2+ response induced by GDNF. Cells transfected
with the Mock-siRNA retain the Ca
2+ response (C). Inhibiting InsP3R with 2-APB (5 mM) abolished the Ca
2+ response induced by GDNF (D), while
inhibiting RyR with ryanodine (a, 20 mM) or dantrolene (b, 10 mM) had no effect (E). Depleting intracellular Ca
2+ stores with the SERCA Ca
2+-ATPase
inhibitor Thapsigargin (1 mM) blocked the Ca
2+ response (F). Zero extracellular Ca
2+ eliminated the GDNF-induced Ca
2+ response (G), whereas a low
extracellular concentration of Ca
2+ (1 mM) produced a normal Ca
2+ response (H).
doi:10.1371/journal.pone.0031258.g002
Table 2. Characteristics of Ca
2+ responses triggered by GDNF in RET
WT cells treated with various inhibitors.
non-responding
a transient
b oscillation
c
%( n)% ( n)% ( n)[ n/N]
d
RET
WT+GDNF/GFRa1 vehicle 8.5 (11) 77.5 (100) 14.0 (18) [129/3]
U73122 98.6 (139) 1.4 (2) 0 (0) [141/3]
PLCc-siRNA 96.9 (62) 3.1 (2) 0 (0) [64/6]
2-APB 54.9 (67) 36.9 (45) 8.2 (10) [122/3]
Ryanodine 25.0 (21) 66.7 (56) 8.3 (7) [84/3]
Thapsigargin 96.8 (150) 2.7 (4) 0.6 (1) [155/3]
Ca
2+ [0 mM]
e 98.9 (176) 1.1 (2) 0 (0) [178/3]
Ca
2+ [1 mM]
e 22.6 (26) 64.3 (74) 13.0 (15) [115/3]
aNon-responding cells have no Ca
2+ increase exceeding 1.25 of the baseline.
bTransient responding cells have one Ca
2+ peak exceeding 1.25 of the baseline.
cOscillatory responding cells have at least three Ca
2+ peaks exceeding 1.25 of the baseline.
d[number of cells/number of experiments].
e[concentration of extracellular Ca
2+].
doi:10.1371/journal.pone.0031258.t002
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2+ response was abolished in RET
WT expressing cells when
extracellular Ca
2+ was removed (Table 2 and Figure 2G). This
result initially suggested that the GDNF-triggered Ca
2+ response
may also derive Ca
2+ from extracellular sources. However, the
RET receptor has four extracellular cadherin-like domains that
contain Ca
2+-binding sites. Thus, extracellular Ca
2+ ions are
required for correct structural alignment of the RET receptor
[26,27]. It was hence possible that the elimination of Ca
2+ from
the medium caused a structural defect in RET. Experiments were
therefore repeated with lower concentrations of Ca
2+ in the
medium. A GDNF-induced Ca
2+ response was observed with as
little as 1 mM of extracellular Ca
2+ (Table 2 and Figure 2H).
Taken together, these data suggest that the GDNF-induced Ca
2+
response comes from ER Ca
2+ stores rather than from the
extracellular milieu.
Downstream Effectors
Two proteins, MAPK and CaMKII, are typically phosphory-
lated when free cytosolic Ca
2+ levels increase. Experiments were
undertaken to determine if the cytosolic Ca
2+ signal induced by
the GDNF/RET/PLCc/InsP3R-mediated cascade of our model
system could influence these two downstream effectors.
Phosphorylation of ERK1/2 was followed on Western blots.
Cells transfected with RET
WT and exposed to GDNF for 2 to
30 min showed time-dependent ERK1/2 phosphorylation
(Figure 3A). Less ERK1/2 phosphorylation was observed in the
presence of BAPTA, which sequesters free cytosolic Ca
2+
(Figure 3A). Indeed BAPTA completely abolished the elevation
of cytosolic Ca
2+ induced by GDNF (Figure S2). Parallel time
course experiments showed that the mutation of Tyr1015 severely
reduced or abolished the ability of RET to induce ERK1/2
phosphorylation (Figure 3B).
CaMKII was also phosphorylated when cells transfected
with RET
WT were exposed to GDNF (Figure 3C). In contrast,
phosphorylation was not observed at all in cells transfected with
the RET
1015 mutation (Figure 3C). The GDNF-evoked CaMKII
phosphorylation was slightly attenuated by sequestering free
cytosolic Ca
2+ with BAPTA or by inhibiting PLC with U73122
(Figure 3C). The U73122 analogue, U73343, which does not
inhibit PLC, did not block phosphorylation (Figure 3C). This set of
experiments suggested that RET-dependent phosphorylation of
ERK1/2 and CaMKII was, at least in part, induced by elevated
levels of Ca
2+.
PLCc-siRNA was thereafter applied to further investigate PLC-
mediated ERK1/2 and CaMKII phosphorylation. Knocking
down PLCc with siRNA suppressed phosphorylation of ERK1/
2 and CaMKII in cells transfected with RET
WT and exposed to
GDNF (Figure 3D).
In summary, these results indicate that GDNF/RET-induced
Ca
2+ signaling phosphorylates ERK1/2 and CaMKII by a
mechanism that absolutely depends on a Tyr at amino acid
1015 of the RET receptor.
Cell Motility
Since GDNF/RET has been reported to regulate cell migration
[9], experiments were performed to examine whether GDNF/
RET-induced Ca
2+ signaling influenced cell motility. A wound
healing assay was used, in which HeLa cells were grown to
confluence and a caliper-measured scratch was made in the
adherent cell layer (Figure 4A). In the absence of GDNF, RET
WT
transfected cells failed to move over the scratched area in the next
6–8 h (Figure 4B). However, when GDNF was included in the
medium the scratch was populated by cells (Figure 4A and B).
Treating the RET
WT transfected cells with BAPTA or U73122
significantly inhibited the observed effect (Figure 4A and B).
Figure 3. GDNF-induced Ca
2+ signaling phosphorylates ERK1/2 and CaMKII. (A–D) Western blot of HeLa cells transfected with RET
WT or
RET
1015 treated with GDNF (100 ng/ml). GDNF triggers time dependent phosphorylation of ERK1/2 (pERK1/2) in RET
WT cells that is suppressed by
BAPTA (10 mM) (A). Less pERK1/2 is observed in cells transfected with RET
1015 than RET
WT (B). GDNF-induced phosphorylation of CaMKII (pCaMKII) or
pERK1/2 is suppressed when blocking PLC with U73122 (5 mM) (C) or knocking down PLCc with siRNA (PLCc-siRNA) (D). Treating RET
WT cells with the
U73122 analogue U73343 (5 mM) had no effect on GDNF-activated pCaMKII or pERK1/2 (C). Increased Caspase-3 cleavage was not detected in cells
treated with the inhibitors BAPTA or U73122 (C).
doi:10.1371/journal.pone.0031258.g003
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significant level of cleaved Caspase-3 was detected by Western blot
(Figure 3C). Cells transfected with the RET
1015 mutant showed
significantly fewer cells in the scratched area after treatment with
GNDF than cells transfected with RET
WT (Figure 4A and B).
RET
1015 did not induce significant Caspase-3 cleavage (Figure 3C),
which suggested that the decreased number of cells in the
scratched area was likely to be an effect of reduced cell motility
caused by the Tyr1015 mutation.
To explore the biological relevance of GDNF/RET-induced
Ca
2+ signaling, we next performed experiments using an in vivo
model of neocortical migration. Immunohistochemistry on mouse
E14.5 brain coronal slices revealed a homogenous RET expression
in the embryonic neocortex (Figure 5A and B). The neural stem
cells of the ventricular zone and more differentiated cells in the
intermediate zone (IZ) and cortical plate were all expressing RET
(Figure 5B and Figure S3). Western blotting (Figure 5C) and
reverse transcription-PCR (Figure 5D), in accordance with the
results obtained by Iba ´n ˜ez and co-workers [10], showed that
neural cells of the cortex were expressing endogenous RET.
Cerebellum, which is known to express high levels of RET, was
used as positive control [28], whereas NIH3T3 cells was used as
negative control [29]. A quantitative measure of mRNA levels
using real-time PCR revealed a weaker, but significant, expression
of RET in the embryonic cortex (Figure 5E). Primary cultures
of cerebral cortical neurons at E14.5 loaded with Fura-2/AM
responded to GDNF (100 ng/ml) with a rapid Ca
2+ response in
8.6% (n=151) of the cells. Expressing RET
WT in primary cortical
neurons produced a rapid Ca
2+ response in 12.9% (n=31) of the
cells (Figure 5F) whereas none of the cells expressing RET
1015
responded to GDNF (n=34). Ex utero electroporation was then
performed to determine whether the Tyr1015 of RET played a
Figure 4. GDNF-induced Ca
2+ signaling stimulates cell motility
in vitro. (A) Cell motility assay in HeLa cells transfected with RET
WT or
RET
1015 and treated with GDNF (100 ng/ml) for 6–8 h. (B) Cell motility
was significantly higher in RET
WT transfected cells treated with GDNF, as
compared to control cells without GDNF. Buffering cytosolic Ca
2+ with
BAPTA (10 mM) or inhibiting PLC with U73122 (5 mM) abolished the cell
motility. GDNF failed to stimulate cell motility in cell transfected with
RET
1015. Bars represent the average number of cells in the scratch.
* P,0.05 versus control.
doi:10.1371/journal.pone.0031258.g004
Figure 5. Endogenous RET is expressed in the embryonic neocortex. Immunohistochemistry of an E14.5 mouse forebrain coronal slice
(A, Scale bars, 250 mm) and cortical plate (CP), intermediate zone (IZ) and ventricular zone (VZ) regions (B, Scale bars, 25 mm) for RET and TuJ1.
Western blot (C), reverse transcription PCR (35 cycles) (D) and real-time PCR (E) analysis for RET in cortical tissue. Cerebellar tissue and NIH3T3 cells
were used as controls. TATA-box binding protein (TBP) was the house keeping gene. (F) Representative single-cell Ca
2+ recording of a RET
WT
expressing primary cortical neuron loaded with Fura-2/AM and subsequently treated with GDNF (100 ng/ml).
doi:10.1371/journal.pone.0031258.g005
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WT or RET
1015
constructs were injected into the lateral ventricles of E14.5
embryonic forebrains and electroporated ex utero (Figure 6A).
Organotypic slice cultures were thereafter prepared from the
electroporated embryos and beads soaked in GDNF (500 ng/ml)
were placed on top of the cortical plate (CP) for 48–72 h
(Figure 6A). Confocal z-stack images of electroporated regions
were then recorded and GFP-positive neuronal progenitor cells in
the ventricular zone (VZ) of the neocortex were analyzed for
migration. RET
WT expressing cells showed a significant 6.360.7-
fold (n=5) increase in migration towards the GDNF-beads in the
CP, as compared to control regions and vehicle (Figure 6B and C).
Blocking PLC with U73122 significantly inhibited the GDNF/
RET-stimulated migratory movement (1.060.1-fold increase,
n=6) of RET
WT expressing cells (Figure 6B). Treating slices with
U73343, a U73122 analogue that does not inhibit PLC, did not
inhibit the observed migration (5.060.4-fold increase, n=6).
These results indicated that PLC-dependent GDNF/RET-signal-
ing played a role in the migratory movement of neuronal pro-
genitor cells overexpressing RET in the VZ.
The RET
1015 construct was thereafter delivered into the
embryonic VZ progenitor cells to further test the influence of
RET Tyr1015 on neuronal migration. GDNF-beads in the CP
failed to stimulate migration (0.360.1-fold increase, n=4) of
neocortical neuronal progenitors expressing the RET
1015 construct
(Figure 6B and D).
In conclusion, our results demonstrate that RET is expressed in
the embryonic neocortex and that GDNF-stimulated neocortical
progenitor migration in the developing brain is modulated by
Tyr1015 of the RET receptor.
Discussion
In the present study we show that GDNF evokes cytosolic Ca
2+
signaling by releasing Ca
2+ from ER stores. The release is de-
pendent on RET, PLCc, and InsP3R and modulates ERK1/2 and
CaMKII phosphorylation. The signaling cascade is mediated by
a single residue of RET since a point mutation of Tyr1015 fails
to nitiate the signaling event. Delivery of the RET Tyr1015
mutant DNA to HeLa cells or neuronal progenitors in the VZ of
mouse embryos impairs GDNF-stimulated cell motility in vitro as
well as in vivo.
The clinical relevance of RET was established when it was
shown that germline mutations of the RET gene were responsible
for two inherited human disorders, those being Hirschsprung’s
disease and MEN2a/b [3,8]. Hirschsprung’s disease is a complex
Figure 6. RET Tyr1015 mediates GDNF-stimulated migration in vivo. (A) Cartoon illustrating mouse embryo electroporation and GDNF-bead
stimulated migration. (B–D) Migration of cortical progenitors in organotypic brain slices from embryos electroporated with RET
WT (C) or RET
1015 (D)
treated without beads (Control) or with beads (indicated with circles) soaked in PBS (Vehicle) or GDNF (500 ng/ml) placed in the cortical plate (CP).
GFP positive RET
WT expressing progenitors (green) stimulated with GDNF beads (B, C) show significantly enhanced migration from the ventricular
zone (VZ) towards the CP, as compared to Control, Vehicle, or inhibition of PLC with U73122 (5 mM). In RET
1015 expressing progenitors GDNF beads
failed to stimulate migration (B, D). Scale bars, 100 mm.
doi:10.1371/journal.pone.0031258.g006
RET-Regulated Calcium Signaling
PLoS ONE | www.plosone.org 6 February 2012 | Volume 7 | Issue 2 | e31258developmental genetic disorder characterized by the absence
of enteric ganglia in the intestinal tract, whereas MEN2a/b is a
cancer syndrome that affects neuroendocrine organs. Various
mutations in the RET gene have been identified and correlated
with these two disorders [2]. Interestingly, the disease phenotypes
of Hirschsprung’s disease and MEN2a/b show partial resem-
blance with previously reported Ca
2+ signaling-dependent disor-
ders [30,31,32,33]. Thus, RET regulated Ca
2+ signaling may be
involved in Hirschsprung’s disease and MEN2a/b. In the case of
RET as an oncogene the results presented herein might be of
clinical benefit as cytosolic Ca
2+ signaling is implicated in general
cancer growth as well as in thyroid cancers of the MEN2b type
[30,34,35]. Tumor cell proliferation has recently been reported in
papillary thyroid carcinoma through a signaling pathway where
RET, MAPK, and CaMKII contributes [15]. However, this study
is the first report of RET-induced Ca
2+ signaling dependent
on a specific phosphotyrosine and will contribute to the overall
understanding of RET-regulated cell mechanisms in human
diseases.
Tyr1062 of RET mediates most of the well characterized
interaction with different adaptor proteins [36,37]. However,
several phosphorylation sites exist and may work independently or
in concert to activate certain cellular processes. For example, a
synchronized activation of RET Tyr905, Tyr1015, and Tyr1062
has been detected in embryonic mouse dorsal root ganglia [36].
Phosphorylation of RET Tyr1015 activates the PLCc pathway
[18] and is important in kidney development because mutation of
this residue abolishes the otherwise competent rescue of Tyr1062
mutations by Tyr1096 in the long isoform of RET [19]. Mutation
of RET Tyr697, a putative protein kinase A (PKA) phosphory-
lation site, causes migration defects in enteric neural crest cells
[38]. This and other observations [39] show a link between cyclic
AMP (cAMP) and RET mediated cell signaling. cAMP levels also
affect cytosolic Ca
2+ signaling influences neuronal survival, re-
generation, and growth cone remodeling [40,41,42]. Our results
demonstrate that RET Tyr1015 mediates a GDNF-triggered
increase in cytosolic Ca
2+ and modulates neuronal progenitor
migration in the embryonic neocortex. The demonstration of RET
expression and function in the developing brain raise the po-
ssibility that the RET receptor plays an important role in the
embryonic cortex.
GDNF/RET has previously been reported to modulate dif-
ferentiation and migration through multiple cell signaling path-
ways. For example, migration of enteric nervous system progenitor
cells and cortical GABAergic neurons has been linked to the
pathways of Ras/ERK and PI3K/Akt [10,12,43], respectively.
The GDNF-stimulated tangential migration of GABAergic
neurons was dependent of GFRa1 but not of RET [10]. More-
over, in a recent study, mice with a homozygous deletion of the
kinesin superfamily protein 26A (KIF26A
2/2) were shown to have
perturbed enteric neuronal development as a result of hypersen-
sitivity to RET signaling [44]. Also Akt/ERK signaling played
an essential role for GDNF/RET-dependent enteric neuronal
development in the KIF26A
2/2 mice. Neurite outgrowth in
human neuroblastoma cells stimulated by RET was shown to be
regulated through downstream activation of Ras/ERK [14]. A
recent study suggests that ERK-dependent GDNF/RET-induced
neurite outgrowth is suppressed by the RET-binding protein
Rap1GAP [45]. In somatotrophs, the pituitary cells secreting
growth hormones during infancy and puberty, activation of
protein kinase C (PKC) and cAMP response element-binding
(CREB) transcription factor are regulated through RET-mediated
signaling pathway [46]. Mice lacking the RET receptor display
early differentiation defects of the dorsal root ganglia somatosen-
sory neurons [47]. Interestingly, all the proteins Akt, CREB, ERK,
PI3K, PKC, and Ras are known to be partially regulated by Ca
2+
signaling [22]. A connection between GDNF/RET and Robo2/
Slit2, yet another signaling pathway known to be regulated by
Ca
2+ signaling [48], in promoting ureteric bud outgrowth has been
reported [49]. Nonetheless, how GDNF/RET triggers Slit2/
Robo2 signaling is not clear but might be attributed to Ca
2+
signaling. Such a Ca
2+ signaling link between RET and Slit2/
Robo2 could, at least in part, be involved in the GDNF-directed
neuronal migration in neocortex of the developing brain.
Our results demonstrate a novel RET signaling pathway where
GDNF stimulates cytosolic Ca
2+ signaling through the PLCc
phosphotyrosine binding site Tyr1015 of RET. This GDNF/
RET/PLCc/InsP3R signaling cascade elevates the cytosolic
Ca
2+ concentration by releasing Ca
2+ from internal ER stores.
The cytosolic Ca
2+ response mediated through Tyr1015 of RET
subsequently phosphorylates the downstream effectors ERK1/2
and CaMKII. Our data also show that RET is homogenously
expressed in the cortex of the developing brain. Mutating Tyr1015
and delivering the DNA to neuronal progenitors in the VZ of
mouse embryos impairs GDNF-stimulated migration in the
developing neocortex. These data further the understanding of
the multifactorial RET receptor in regulating multiple signaling
pathways and biological processes.
Materials and Methods
Cells, tissues and plasmids
Human cervical carcinoma HeLa cells and mouse embryonic
NIH3T3 fibroblasts (obtained from the American Type Culture
Collection), were grown in Dulbecco’s modified Eagle’s medium
containing 10% fetal bovine serum. Embryonic brain slices were
obtained from wild type CD1 pregnant mice euthanized at 14.5
days postcoitum. Cerebral cortical neurons in primary culture
were prepared from CD1 mouse fetuses at E15.5 as described
elsewhere [24]. Experiments were approved by the Stockholm
North Ethical Committee on Animal Experiments (Permit Nu-
mber: N370/09). RET mutants were harbored and expressed in
PJ7V plasmids and subcloned into peGFP vectors (Clonetech) to
make fluorescent constructs, as previously described [37].
Reagents
Reagents and concentrations, unless otherwise stated, were as
follows: GDNF (100 ng/ml, R&D Systems), GFRa1/FC chimera
(400 ng/ml, R&D Systems), U73122 (5 mM, Sigma-Aldrich),
U73343 (5 mM, Sigma-Aldrich), 2-aminoethoxydiphenyl borate
(2-APB, 5 mM, Sigma-Aldrich), Ryanodine (20 mM, Sigma-
Aldrich), Dantrolene (10 mM, Tocris), Thapsigargin (1 mM,
Sigma-Aldrich), and bis(2-aminophenoxy)ethane tetraacetic acid
(BAPTA, 10 mM, Molecular-Probes).
Cytosolic Ca
2+ imaging
Cells were loaded with the Ca
2+-sensitive fluorescence indicator
Fura-2/AM (5 mM, Molecular-Probes) in cell culture medium
at 37uC with 5% CO2 for 30 min. The Ca
2+ measurements were
conducted at 37uC in a heat-controlled chamber (Warner In-
struments) with a cooled back-illuminated EMCCD camera
Cascade II:512 (Photometrics) mounted on an inverted micro-
scope Axiovert 100M (Carl Zeiss) equipped with a LCI Plan-
Neofluar 256/0.8NA water immersion lens (Carl Zeiss). Excita-
tion at 340, 380 and 495 nm took place using a Lambda LS
xenon-arc lamp (Sutter Instrument) equipped with a Lambda
10-3 filter-wheel (Sutter Instrument) and a SmartShutter (Sutter
Instrument). Emission wavelengths were detected at 510 nm, and
RET-Regulated Calcium Signaling
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(Molecular Devices) was used to control all devices and to
analyze the acquired images. The experiments were performed
in Krebs-Ringer’s buffer containing 119.0 mM NaCl, 2.5 mM
KCl, 2.5 mM CaCl2, 1.3 mM MgCl2, 1.0 mM NaH2PO4,
20.0 mM Hepes (pH 7.4), and 11.0 mM dextrose. Drugs were
bath-applied.
Western blotting
Cells were lysed by sonication and protein concentrations were
determined using a BCA protein assay (Pierce). Equal amounts of
cellular protein were separated by sodium dodecyl sulphate gel
electrophoresis, followed by wet transfer to PVDF membranes.
Membranes were blocked in 5% skim milk in Tris-buffered saline
solution plus 0.5% Tween-20 for 1 h before being incubated with
primary antibodies (1:1000 ERK1/2, 1:1000 pERK1/2, 1:1000
pCaMKII, 1:1000 Cleaved Caspase-3, all from Cell Signaling,
1:1000 pPLCc, 1:2000 RET H-300 from Santa Cruz or 1:200
RET AF482 from R&D Systems) overnight at 4uC and re-
incubated with horseradish peroxidase-conjugated secondary
antibody (1:5000–10000 from GE Healthcare) for 1 h. Immuno-
reactive bands were visualized using an enhanced chemilumines-
cence kit (GE Healthcare).
Immunohistochemistry
Mouse brain slices were cut (30–100 mm) with a vibratome
(Leica), fixed with 4% PFA overnight at 4uC and then incubated in
a blocking solution (PBS, 5% Normal Goat serum, 0.1–0.3%
Triton X100, 1% Bovine Serum Albumin) for 1 h at 24uC.
Blocking solution was replaced by washing solution (PBS, 0.5%
Normal Goat serum, 0.3% Triton X100, 1% Bovine Serum
Albumin) containing the appropriate dilution of the primary
antibody overnight at 4uC. Primary antibodies used were anti-
RET (1/1000, R&D Systems) or anti-Tuj1 (1/400, Millipore).
Alexa Fluor 488 and 555 secondary antibodies (Invitrogen) were
used to reveal the primary antibodies (1/1000, 1–2 h, 24uC). TO-
PRO-3 (Invitrogen) and only secondary antibody staining were
used as control (Figure S3). Slices were mounted in Glycergel
(Invitrogen) and observed using confocal microscopy (Carl Zeiss
LSM 5 Exciter). Images were processed using the Fiji software
(NIH).
Cell motility assay
Cells transfected with RET
WT and RET
1015 were seeded in
plastic culture dishes and grown to confluence. A 1.2-mm wide
region devoid of cells was made in the dish using a 200-mlp l a s t i c
pipette tip held against a caliper. Cells were starved overnight
and then pretreated with the Ca
2+ inhibitors for 30 min before
GDNF and GFRa1 stimulation for 6–8 h. Quantification of
cells moving into the empty region were performed by count-
ing the number of cells within equal areas using bright-field
light microscopy. Images were captured using a digital camera
(Olympus C-7070) and processed in the Photoshop Lightroom
software (Adobe).
siRNA knock down
Cells were transfected with 80 nM specific small interfering
RNA (siRNA) against PLC (PLCG1 ON-TARGETplus SMART-
pool, art nr L-003559-00-0005, Dharmacon) or non-targeting
siRNA (Mock-siRNA) as a control (Stealth nontarget siRNA, GC
medium composition) by using Lipofectamine 2000 (Invitrogen)
according to the manufacturer’s protocol. Efficiency was deter-
mined by Western Blot towards PLCc.
Transfections and whole embryo electroporation
Transfection of HeLa cells was conducted using Lipofectamine
2000 (Invitrogen) in Opti-MEM (Invitrogen) according to the
manufacturer’s protocol. Electroporation of mouse embryos and
organotypic brain slice culture were conducted as described
previously [50,51]. Briefly, a wild type CD1 pregnant mouse was
euthanized at 14.5 days postcoitum and the embryos were taken
out. A glass capillary was inserted into the lateral ventricle of
the embryos, and 2–4 ml of 0.5 mg/ml RET
WT or RET
1015
plasmids with 0.01% Fast Green FCF (Sigma-Aldrich) in
phosphate buffered saline (PBS) were injected (Figure 6A). After
injection, the forebrain area of an embryo was held with a forceps-
type electrode (BTX Harvard Apparatus) with the anode on the
dorsal cortical side of the injected ventricle and five cycles of
square electric pulses (50 V, 50 ms) with 950 ms intervals were
delivered to the embryo using an electroporator (BTX Harvard
Apparatus). Experiments were approved by the Stockholm North
Ethical Committee on Animal Experiments (Permit Number:
N370/09).
After electroporation, coronal slices (300 mm) of the forebrain
were obtained using a vibratome (Leica) and cultured in Ne-
urobasal medium supplemented with B27. A maximum of three
beads (Cibacron blue CGA, Sigma-Aldrich) of diameter ,100 mm
soaked (4–6 h, 4uC) in GDNF (500 ng/ml) or in PBS were placed
in the cortical plate (CP) as described [10]. After 48–72 h, slices
were fixed with PFA 4% overnight at 4uC and stained with TO-
PRO-3 (Invitrogen). For each separate condition, superimposed z-
stack confocal images were analyzed for number of GFP-positive
progenitors per mm
3 in a spherical region with diameter twice of
the GDNF-bead (Figure 6C and D). A region in a similar location
of the slice, more than ,400 mm away from the beads, was used to
normalize the results. Experiments where beads were misplaced to
other areas than the CP were discarded from the analysis.
Reverse Transcription and Real Time PCR
Total RNA was extracted from cultured cortical neurons using
RNeasy kit (Qiagen). RNA quality and quantity were measured
with Nanodrop 2000 (Thermo Scientific). RNA was then treated
with DNaseI (Biolabs) and reverse transcription was conducted
with Superscript II reverse transcriptase (Invitrogen) according
to manufacturer’s protocol. cDNA from NIH3T3 cells and mouse
E15.5 cerebellum served as negative and positive control, re-
spectively. Reverse transcription-PCR analysis was performed
using Taq Polymerase (Invitrogen), and primers were as follows:
RET forward GTACACAAACACACTCCTCTCAGG, reverse
CAGGCTCCTGTTGAGAATCAG, TATA-box binding protein
(TBP) forward GGGGAGCTGTGATGTGAAGT, reverse
CCAGGAAATAATTCTGGCTCA. The thermal cycling condi-
tions were: 94uC for 4 min, 35 cycles of 94uC (30 s), 60uC (30 s),
and 72uC (30 s) and at the end 72uC for 4 min. The PCR pro-
ducts were separated on 2% agarose gel and visualized under
ChemiDoc XRS+ (Biorad) after staining with GelRed (Biotium).
Real-time PCR was performed in triplicates using SYBR green
PCR master mix according to the manufacture’s instruction
(Applied Biosystems) in a 7900HT Fast real-time PCR system
(Applied Biosystems). Products were analyzed with ABI 7900HT
Sequence Detection System (Applied Biosystems). 2
2DCt values
were used to calculate the relative expression levels and were given
as mean 6 SEM.
Data analysis
The Ca
2+ recording data were normalized and cells were
considered responsive to a treatment if the mean fluorescence was
increased by at least 25% over the baseline. The data were
RET-Regulated Calcium Signaling
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significance was accepted at P,0.05.
Supporting Information
Figure S1 Western blotting of HeLa cells transfected
with RET
WT or RET
1015. (A) Cells expressing RET
WT or
RET
1015 treated with GDNF (100 ng/ml) show normal phos-
phorylation of RET Tyrosine residues. (B) Small interfering RNA
(siRNA) against PLCc (PLCc-siRNA) knocked-down the PLCc
protein level in HeLa cells expressing RET
WT.
(PDF)
Figure S2 GDNF/RET-induced Ca
2+ signalling is inhib-
ited by BAPTA. Representative single-cell Ca
2+ recording of a
Fura-2/AM-loaded HeLa cell transfected with RET
WT and
treated with GDNF (100 ng/ml). Quenching intracellular Ca
2+
with BAPTA (10 mM) abolishes the GDNF/RET-triggered Ca
2+
response.
(PDF)
Figure S3 Immunohistochemistry control of embryonic
cortex with only secondary antibodies. Immunohistochem-
istry of an E14.5 mouse forebrain cortex coronal slice (A, Scale
bar, 250 mm) and cortical plate (CP), intermediate zone (IZ) and
ventricular zone (VZ) regions (B, Scale bars, 25 mm) with only
secondary antibodies Alexa488 and Alexa555.
(PDF)
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